Single-fraction stereotactic body radiation therapy appeared safe and effective for patients with up to three oligometastatic lung tumors, according to results of the phase 2 SAFRON II trial presented at the virtual ASTRO Annual Meeting.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.